Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

计划入组 5 人 · 首次发布于 2018 年 3 月 29 日

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery

计划入组 9 人 · 首次发布于 2026 年 6 月 30 日

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

计划入组 9 人 · 首次发布于 2026 年 7 月 23 日

mRNA-4157

mRNA-based antibody therapeutic program (nanoparticle, cancer)

mRNA vaccine

Jaime Leandro Foundation for Therapeutic Cancer Vaccines

United States

AIM VACCINE

China

EVIDENCE-BASED PRACTICE INSTITUTE, INC.

United States

Novel mRNA Cancer Vaccine Prevents Melanoma Recurrence in High-Risk Patients

Investigational mRNA Vaccine Shows Promise in Fighting Pancreatic Cancer

Experimental mRNA Cancer Immunotherapy Shows Promise in High-Risk Melanoma, Former FDA Chief Says